ARCHIVES

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

March 23, 2001

NCAB Approves Fallout Study On Split Vote

March 13, 1981

Watson To Head Genome Research

September 30, 1988